Literature DB >> 26669632

Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B.

Y Li1, Y-S Huang2, Z-Z Wang1, Z-R Yang2, F Sun2, S-Y Zhan2, X-E Liu1, H Zhuang1.   

Abstract

BACKGROUND: Transient elastography is a non-invasive method for staging liver fibrosis. The meta-analysis using the hierarchical models to evaluate the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B was rarely reported. AIM: A meta-analysis using the hierarchical models was performed to assess transient elastography for diagnosing and stage liver fibrosis in patients with chronic hepatitis B.
METHODS: Electronic databases were searched and studies were identified to assess the diagnostic accuracy of transient elastography in CHB patients for staging fibrosis F ≥ 2, F ≥ 3 and F = 4 with liver biopsy as a reference standard. The hierarchical summary receiver operating characteristic curve and the bivariate models were performed to evaluate the diagnostic accuracy of transient elastography, and meta-regression analyses were performed to explore the heterogeneity. The quality Assessment of Diagnostic Accuracy Studies-2 tool was used to assess the quality of studies.
RESULTS: Twenty-seven studies with a total of 4386 patients were included in the meta-analysis. The summary sensitivity of transient elastography for staging fibrosis F ≥ 2, F ≥ 3 and F = 4 was 0.806 (95% CI, 0.756-0.847), 0.819 (95% CI, 0.748-0.874) and 0.863 (95% CI, 0.818-0.898), respectively, and the summary specificity was 0.824 (95% CI, 0.761-0.873), 0.866 (95% CI, 0.824-0.899) and 0.875 (95% CI, 0.840-0.903), respectively. The corresponding area under the summary receiver operating characteristic curve was 0.88 (95% CI, 0.85-0.91), 0.91 (95% CI, 0.88-0.93) and 0.93 (95% CI, 0.91-0.95), respectively. Meta-regression showed that patient age contributed to heterogeneity.
CONCLUSIONS: Transient elastography performs well to diagnose liver fibrosis in patients with chronic hepatitis B, which may reduce the use of liver biopsy.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26669632     DOI: 10.1111/apt.13488

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  36 in total

1.  Strain elastography for noninvasive assessment of liver fibrosis: A prospective study with histological comparison.

Authors:  Cheng Fang; Sanjiv Virdee; Joseph Jacob; Olivia Rufai; Kosh Agarwal; Alberto Quaglia; Daniel J Quinlan; Paul S Sidhu
Journal:  Ultrasound       Date:  2019-07-23

2.  Comparison of three cut-offs to diagnose clinically significant portal hypertension by liver stiffness in chronic viral liver diseases: a meta-analysis.

Authors:  Jinzhen Song; Zida Ma; Jianbo Huang; Shiyu Liu; Yan Luo; Qiang Lu; Philipp Schwabl; Romanas Zykus; Ashish Kumar; Matthew Kitson
Journal:  Eur Radiol       Date:  2018-06-01       Impact factor: 5.315

Review 3.  Noninvasive imaging assessment of portal hypertension.

Authors:  Paul Kennedy; Octavia Bane; Stefanie J Hectors; Aaron Fischman; Thomas Schiano; Sara Lewis; Bachir Taouli
Journal:  Abdom Radiol (NY)       Date:  2020-09-14

Review 4.  Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions.

Authors:  Paul Kennedy; Mathilde Wagner; Laurent Castéra; Cheng William Hong; Curtis L Johnson; Claude B Sirlin; Bachir Taouli
Journal:  Radiology       Date:  2018-03       Impact factor: 11.105

5.  Hepatitis B core antibody and liver stiffness measurements predict HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients with minimally elevated alanine aminotransferase (ALT) levels.

Authors:  Xihua Fu; Haibo Lou; Fang Chen; Xueping Gao; Zhanzhou Lin
Journal:  Clin Exp Med       Date:  2020-02-12       Impact factor: 3.984

Review 6.  Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection.

Authors:  Pathik Parikh; John D Ryan; Emmanuel A Tsochatzis
Journal:  Ann Transl Med       Date:  2017-02

7.  Diagnosis of liver fibrosis in patients with hepatitis B-related liver disease using ultrasound with wave-number domain attenuation coefficient.

Authors:  Danqing He; Chaoxue Zhang; Wenqian Qiu; Qinxiu Xie
Journal:  Turk J Gastroenterol       Date:  2020-12       Impact factor: 1.852

Review 8.  Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

Authors:  Ivana Mikolasevic; Lidija Orlic; Neven Franjic; Goran Hauser; Davor Stimac; Sandra Milic
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

Review 9.  Principles of ultrasound elastography.

Authors:  Arinc Ozturk; Joseph R Grajo; Manish Dhyani; Brian W Anthony; Anthony E Samir
Journal:  Abdom Radiol (NY)       Date:  2018-04

10.  Longitudinal monitoring of liver fibrosis status by transient elastography in chronic hepatitis B patients during long-term entecavir treatment.

Authors:  Sheng-Di Wu; Li-Li Liu; Ji-Lin Cheng; Yun Liu; Li-Sha Cheng; Si-Qi Wang; Wei Ma; Li-Ping Chen; Yu-Jen Tseng; Ji-Yao Wang; Xi-Zhong Shen; Wei Jiang
Journal:  Clin Exp Med       Date:  2018-04-25       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.